HOME >> BIOLOGY >> NEWS
Jeffrey Friedman, discoverer of leptin, receives Gairdner, Passano awards

Rockefeller University's Jeffrey M. Friedman, M.D., Ph.D., a molecular geneticist whose discovery of the hormone leptin and its role in regulating body weight has changed our understanding of the causes of human obesity, has received two prestigious awards for this work: the Gairdner Foundation International Award and the Passano Foundation Award.

Prior to his groundbreaking research, little was known about the components of the biologic system that controls weight, with many scientists questioning the very existence of such a homeostatic system. With leptin and Friedman's subsequent studies, the logic of an entirely new physiologic system has been established with direct implications for the pathophysiology of human obesity.

Friedman, Marilyn M. Simpson Professor and head of the Laboratory of Molecular Genetics at Rockefeller and an investigator at the Howard Hughes Medical Institute, received the Gairdner Award and gave a talk on the genetic roots of obesity on Tues., April 5 in Toronto, Canada. On Tues., April 19, he will receive the Passano Award at the Center Club in Baltimore, Md., and give the Passsano Foundation Award lecture at Johns Hopkins University School of Medicine.

Discovery of leptin and its role in regulating body weight

In December 1994, Friedman and his colleagues published a landmark paper in the journal Nature, in which they identified a gene in mice and humans called obese (ob) that codes for a hormone he later named leptin, after the Greek word leptos, for thin. Friedman and colleagues showed that leptin is a hormonal signal made by the body's fat cells that regulates food intake and energy expenditure. Leptin has powerful effects on reproduction, metabolism, other endocrine systems and even immune function.

Mice that lack ob, and thus do not produce leptin, are massively obese, weighing as much as three times as their normal littermates. Friedman showed that after normal and ob mice are injected
'"/>

Contact: Joseph Bonner
bonnerj@rockefeller.edu
212-327-8998
Rockefeller University
13-Apr-2005


Page: 1 2 3 4

Related biology news :

1. Q&A with Jeffrey Sachs on July 10 at Soils Congress
2. Wiley presents its 2004 Gaden Award to Jeffrey A. Hubbell
3. Carnegie Mellons Peter Adams receives EPA research grant
4. Philadelphia ecologist receives top Mongolia honor
5. VIB scientist receives major research grant
6. Maynard Olson receives $500,000 Gruber Genetics Prize
7. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
8. Wright State scientist receives grant to help clean up polluted American harbors
9. UCR biologist receives $1.75 million grant to study plant-threatening bacteria
10. Michael R. Zalutsky receives SNMs 2007 Paul C. Aebersold Award
11. Nobel laureate James Watson receives personal genome in ceremony at Baylor College of Medicine

Post Your Comments:
(Date:5/24/2013)... and grow by avoiding detection and destruction by the ... to eliminate cancer cells; however, there are many factors ... Regulatory T cells are immune cells that function to ... the Journal of Clinical Investigation , researchers led ... T cells that infiltrate tumors express proteins that can ...
(Date:5/24/2013)... A conference of 500 leading water scientists from around ... major reforms, "in the short span of one or ... on Earth will be living under the handicap of ... resource for which there is no substitute. This handicap ... , The scientists bluntly pointed to chronic underlying problems ...
(Date:5/23/2013)... than 284 million tons of cargo, transit the Panama Canal ... for the Panama Canal Authority. Each time a ship passes ... from Gatun Lake, which is also a source of water ... , However, the advent of very large "super" cargo ships, ... has demanded change. The Panama Canal is being expanded to ...
Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
(Date:5/23/2013)... MD (PRWEB) May 23, 2013 Can ... off from work motivate members of the public to ... researchers including Johns Hopkins Carey Business School ... emphatic yes. Pointing to a large body of recent ... in the May 24, 2013, issue of Science that ...
(Date:5/23/2013)... May 23, 2013 The maker community ... types of inventions. They focus on learning practical skills ... community gravitate toward bringing their ideas to life via ... Movement, works on making projects using biology. Glowing Plant ... plants to make them glow with bioluminescence genes, and ...
(Date:5/23/2013)... , May 23, 2013 BioTrends Research ... advisory firms for specialized biopharmaceutical issues, finds that, ... infectious disease specialists reported that in the past ... intentionally delaying treatment) in anticipation of the next ... months ago, when only 6 percent reported that ...
(Date:5/23/2013)... Mass. , May 23, 2013 Pressure ... announced that the Company will host a teleconference to ... provide a business update. The teleconference information is provided ... 11:00 a.m. Eastern Daylight Time (EDT) Dial-in: ... ); (302) 607-2001 (Int,l) Passcode: VS22823 For ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2
Cached News: